Vendor, Cambridge, MA, part of Genzyme Corp.
Genzyme Corporation
UEI X2XMAQLR9DA8, CAGE 1HBD8
4 awards and -$117,888 obligated between January 29, 2024 and August 12, 2026, 100% under full and open competition, against 250.5 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| Pharmaceutical Preparation ManufacturingNAICS 325412 | -$117,888 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 4 |
| Delivery Order | 2 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 36E79724A0018June 5, 2024, Full and Open Competition, 1 offers | Nac PharmaceuticalsDepartment of Veterans Affairs | BPA for Cerdelga, Caprelsa, and LemtradaNAICS 325412, PSC 6505 | $0 |
| 36F79719D0153January 29, 2024, Full and Open Competition, 999 offers | Nac Federal Supply ScheduleDepartment of Veterans Affairs | TC Change.NAICS 325412, PSC 6505 | $0 |
| 36C26223F0045Delivery Order, November 18, 2024, Full and Open Competition, 1 offers | 262-Network Contract Office 22Department of Veterans Affairs | Eliglustat Cerdelga 84MG for VA SDNAICS 325412, PSC 6505 | -$14,636 |
| 36C26023F0186Delivery Order, July 17, 2024, Full and Open Competition, 1 offers | 260-Network Contract Office 20Department of Veterans Affairs | Eliglustat (Cerdelga) 84MG Oral Capsule - Puget Sound VahcsNAICS 325412, PSC 6505 | -$103,252 |
- Places of performance
- PennsylvaniaWashington
- Product and service codes
- 6505 Drugs and Biologicals
- Transactions
- 49 across 4 awards